Shares of Nicox SA (OTCMKTS:NICXF – Get Free Report) shot up 7.1% on Thursday . The company traded as high as $0.30 and last traded at $0.30. 8,000 shares traded hands during mid-day trading, The stock had previously closed at $0.28.
Nicox Stock Up 7.1%
The company has a fifty day moving average of $0.25 and a two-hundred day moving average of $0.25.
About Nicox
Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.
Further Reading
- Five stocks we like better than Nicox
- The Basics of Support and Resistance
- The Market Rally Is Gaining Momentum—Don’t Get Left Behind
- What is the FTSE 100 index?
- High-Flying GE Aerospace Drops After Blowout Q2 — What Now?
- How to Buy Gold Stock and Invest in Gold
- Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate
Receive News & Ratings for Nicox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nicox and related companies with MarketBeat.com's FREE daily email newsletter.
